Dillard's, Inc. DDS
664.07
18.41
2.85%
as of 25 Sep
- Market cap
- $10.2B
- P/E
- 15.2×
Follow DDS
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
16.29 | 17.38 | 13.53 | 13.48 |
P/S ratio |
1.41 | 1.51 | 1.35 | 1.39 | |
P/FCF ratio |
11.87 | 15.26 | 11.39 | 14.03 | |
P/Operating CF |
50.25 | 46.92 | 24.42 | (247.17) | |
P/B ratio |
4.58 | 5.57 | 4.39 | 4.33 | |
Price to Tangible BV |
4.58 | 5.57 | 4.39 | 4.33 | |
EV/Sales |
1.29 | 1.43 | 1.21 | 1.27 | |
EV/EBITDA |
9.53 | 10.76 | 9.12 | 9.15 | |
EV/Operating CF |
9.83 | 13.05 | 9.42 | 11.53 | |
EV/FCF |
10.84 | 14.41 | 10.24 | 12.75 | |
Quick Ratio |
0.95 | 1.23 | 1.14 | 1.49 | |
Current Ratio |
2.19 | 2.65 | 2.37 | 3.03 | |
Net Debt/EBITDA |
(3.78) | (2.18) | (3.31) | (4.80) | |
Debt/Assets |
12.14% | 14.88% | 12.61% | 11.35% | |
Debt/Equity |
0.26 | 0.29 | 0.26 | 0.20 | |
Asset Turnover |
1.57 | 1.87 | 1.64 | 1.78 | |
Operating CF/Net income |
1.44 | 1.04 | 1.45 | (0.38) | |
Capex/Depreciation |
(0.64) | (0.03) | (0.39) | (0.50) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
29.54% | 23.27% | 27.95% | 28.99% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.10 | 0.07 | 0.11 | 0.11 | |
Graham Number |
329.50 | 305.11 | 350.35 | 365.17 | |
Earnings Yield |
6.14% | 5.75% | 7.39% | 7.42% | |
Free Cash Flow Yield |
8.42% | 6.55% | 8.78% | 7.13% | |
Revenue per Share |
95.50 | 127.08 | 101.72 | 97.99 | |
Operating CF per Share |
11.94 | 13.49 | 23.31 | (2.38) | |
Capex per Share |
(1.84) | (0.09) | (1.09) | (1.42) | |
Free Cash Flow per Share |
10.10 | 13.40 | 22.22 | (3.80) | |
Cash per Share |
85.47 | 68.54 | 90.76 | 80.72 | |
Shareholders Equity per Share |
130.98 | 113.64 | 129.70 | 135.78 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
130.98 | 113.64 | 129.70 | 135.78 | |
Free Cash Flow |
157.73 | 209.75 | 346.94 | (59.34) | |
Working Capital |
1,723.58 | 1,484.49 | 1,759.74 | 1,797.51 | |
Capital Expenditures |
(28.73) | (1.41) | (17.04) | (22.17) | |
Net Current Asset Value |
916.01 | 660.52 | 934.86 | 1,052.11 | |
EV/EBIT |
11.86 | 13.58 | 11.46 | 11.39 | |
Capex to Sales |
0.02 | 0.00 | 0.01 | 0.01 | |
Net Profit Margin |
8.71% | 10.24% | 15.77% | 6.38% | |
Price to Operating Income |
12.98 | 14.39 | 12.75 | 12.53 | |
| Other line items | |||||
Average Receivables |
53.32 | 47.71 | 51.99 | 54.57 | |
Average Payables |
1,214.48 | 783.71 | 1,069.04 | 777.96 | |
Average Inventory |
1,700.14 | 1,186.57 | 1,487.91 | 1,251.51 | |
Average Assets |
4,215.56 | 3,518.04 | 4,022.39 | 3,717.17 | |
Average Common Equity |
2,004.22 | 1,787.57 | 1,941.72 | 2,019.90 |
Columns are period end dates